started · updated
Researchers develop wearable biosensor for continuous cardiac monitoring
Researchers at McMaster University and the University of Waterloo have developed a minimally invasive wearable biosensor designed to continuously monitor cardiac troponin I (cTnI), a critical biomarker for heart muscle injury.
The device utilizes a patch equipped with hydrogel microneedles that collect interstitial fluid from beneath the skin. This fluid is then analyzed by a sensing system combining high-affinity antibodies and aptamers, which allows for the continuous electrochemical detection of proteins even at very low concentrations.
The technology aims to address the risks associated with post-surgical care. Approximately 300 million people undergo non-cardiac surgery annually, and roughly 20 percent of high-risk patients experience myocardial injury after surgery. Because about 90 percent of these injuries are silent and lack obvious symptoms, traditional blood tests can be difficult to administer once patients have been discharged from the hospital. This wearable platform could provide a way to detect complications without the need for repeated, invasive blood draws.
Entities
Leyla Soleymani · McMaster University · NexusHealth · University of Waterloo